<- Go Home

Boule Diagnostics AB (publ)

Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics companies. Boule Diagnostics AB (publ) was founded in 1956 and is headquartered in Spånga, Sweden.

Market Cap

SEK 423.3M

Volume

23.5K

Cash and Equivalents

SEK 40.9M

EBITDA

SEK 63.4M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

SEK 252.0M

Profit Margin

43.75%

52 Week High

SEK 12.62

52 Week Low

SEK 8.66

Dividend

N/A

Price / Book Value

0.85

Price / Earnings

15.79

Price / Tangible Book Value

1.04

Enterprise Value

SEK 560.8M

Enterprise Value / EBITDA

8.68

Operating Income

SEK 45.6M

Return on Equity

5.57%

Return on Assets

3.65

Cash and Short Term Investments

SEK 40.9M

Debt

SEK 178.4M

Equity

SEK 498.0M

Revenue

SEK 576.0M

Unlevered FCF

-SEK 9.4M

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches